4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular DegenerationGeographic Atrophy, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, age-related macular degeneration, eye disorder, macular degeneration, nervous system disorder, retinal degeneration, retinal disorder, vision disorder, wet macular degenerationActive, not recruitingPhase 22026-09-22NCT05230537
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationGeographic Atrophy Secondary to Age-related Macular DegenerationRecruitingPhase 22026-09-09NCT07441642
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLEeye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorderRecruitingPhase 32026-05-18NCT06996080
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKeye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorderRecruitingPhase 32026-05-18NCT06990399